Subtype
Colon Neoplasm
CI-CAN-00004992Explore in graph →
Non-malignant271 active trials5 approved drugs17 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00004992Explore in graph →
Clinical trials
1,560 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04977882 | Abdominal Drainage, Postoperative Antibiotico-prophylaxis and CME With D3 Lyphadenectomy Effect on Gastrointestinal Function in Laparoscopic Right Hemicolectomy With Intracorporeal Anastomosis for Right Colon Cancer | completed | Early Phase 1 | 36 | University of Rome Tor VergataOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT06135558 | Clinical Significance of Marginal Acute Inflammation for Stage II Colon Cancer | completed | — | 1,167 | Sun Yat-sen UniversityOTHER | 0 | Nov 18, 2023 |
| clinicaltrials |
| NCT04196062 | EndoMaster EASE System for Treatment of Colorectal Lesions(MASTERCESD) | completed | N/A | 45 | Chinese University of Hong KongOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT05497726 | Fluorescent Sentinel Lymph Node Identification in Colon Carcinoma Using Intravenous Bevacizumab-800CW(IBIZA-2) | completed | N/A | 5 | Meander Medical CenterOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT00019760 | Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver | completed | Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Oct 31, 2023 | clinicaltrials |
| NCT03750786 | A Study to Compare the Efficacy of Arfolitixorin Versus Leucovorin in Combination With 5 Fluorouracil, Oxaliplatin, and Bevacizumab in Patients With Advanced Colorectal Cancer(AGENT) | completed | Phase 3 | 490 | Isofol Medical ABINDUSTRY | 10 | Oct 26, 2023 | clinicaltrials |
| NCT03854799 | Immunotherapy In Locally Advanced Rectal Cancer(AVANA) | completed | Phase 2 | 101 | Gruppo Oncologico del Nord-OvestOTHER | 1 | Oct 19, 2023 | clinicaltrials |
| NCT05727007 | CT and MRI in Preoperative Colon Cancer Staging | completed | N/A | 120 | Larissa University HospitalOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT01376505 | Vaccine Therapy in Treating Patients With Metastatic Solid Tumors | completed | Phase 1 | 65 | Robert WesolowskiOTHER | 1 | Sep 15, 2023 | clinicaltrials |
| NCT00591279 | Cancer Control Following Polypectomy | completed | — | 110 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 13, 2023 | clinicaltrials |
| NCT01606098 | The Role of Surgery of the Primary Tumour in Patients With Synchronous Unresectable Metastases of Colorectal Cancer(CAIRO4) | completed | Phase 3 | 206 | Dutch Colorectal Cancer GroupOTHER | 2 | Sep 13, 2023 | clinicaltrials |
| NCT03735407 | Safety,Usability and Compliance of Using C-Scan System for Providing Information on Colonic Polypoid Lesions and Masses(C-Scan) | completed | N/A | 45 | Check-Cap Ltd.INDUSTRY | 1 | Sep 13, 2023 | clinicaltrials |
| NCT03827967 | Trial of PalloV-CC in Colon Cancer | completed | Phase 1 | 24 | George E. PeoplesINDUSTRY | 1 | Sep 13, 2023 | clinicaltrials |
| NCT04880772 | Clinical Trial Comparing Standard Care Versus Prehabilitation in Patients Undergoing Cancer Surgery(SPECS) | completed | N/A | 42 | East Lancashire Hospitals NHS TrustOTHER | 1 | Sep 7, 2023 | clinicaltrials |
| NCT06009484 | VTE Incidence After Curative Colon Cancer Surgery in an ERAS Program | completed | — | 2,141 | Nordsjaellands HospitalOTHER | 0 | Aug 24, 2023 | clinicaltrials |
| NCT02726360 | Physician Use of Non-English Language Skills in Cancer Care | completed | — | 71 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 23, 2023 | clinicaltrials |
| NCT04716010 | Developing and Evaluating Product Messaging | completed | N/A | 4,160 | University of North Carolina, Chapel HillOTHER | 1 | Aug 18, 2023 | clinicaltrials |
| NCT00994864 | Preoperative Chemosensitivity Testing to Predict Treatment Benefit in Adjuvant Stage III Colon Cancer(PePiTA) | completed | N/A | 235 | Jules Bordet InstituteOTHER | 1 | Aug 7, 2023 | clinicaltrials |
| NCT02232152 | CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery | completed | Phase 1 | 19 | Wake Forest University Health SciencesOTHER | 1 | Aug 7, 2023 | clinicaltrials |
| NCT03602079 | Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene | completed | Phase 1 / Phase 2 | 49 | Klus Pharma Inc.INDUSTRY | 1 | Aug 3, 2023 | clinicaltrials |
| NCT04971304 | Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars | completed | — | 16,506 | Catherine M. LockhartOTHER | 0 | Jul 27, 2023 | clinicaltrials |
| NCT03717519 | Elevated Platelet Count as Prognostic Factor in Colorectal Cancer With Synchronous Liver Metastases(PLTCRC) | completed | — | 196 | Azienda Ospedaliera Universitaria Integrata VeronaOTHER | 1 | Jul 20, 2023 | clinicaltrials |
| NCT05943951 | Italian Study on the Right Hemicolectomy: How the Lymphadenectomy is Performed(CoDIG-2) | completed | — | 788 | Gabriele AnaniaOTHER | 1 | Jul 13, 2023 | clinicaltrials |
| NCT05498051 | Fluorescent Sentinel Lymph Node Identification in Colon Carcinoma Using Submucosal Bevacizumab-800CW.(IBIZA-1) | completed | N/A | 5 | Meander Medical CenterOTHER | 1 | Jul 7, 2023 | clinicaltrials |
| NCT03428126 | Study of Durvalumab (MEDI4736) (Anti-PD-L1) and Trametinib (MEKi) in MSS Metastatic Colon Cancer | completed | Phase 2 | 29 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 15, 2023 | clinicaltrials |
| NCT04902144 | Clinical Outcomes for Offering Genetic Testing in a Tiered Approach | completed | N/A | 6 | Fred Hutchinson Cancer CenterOTHER | 1 | Jun 9, 2023 | clinicaltrials |
| NCT05030090 | Integrative Nutrition Care Plan for the Patient With Liver and Colorectal Cancer | completed | N/A | 66 | Taipei Medical UniversityOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT05872334 | The Safety and Feasibility of MONOFIX on Fascial Closure of Mid-line Wound After Minimally Invasive Colorectal Cancer Surgery | completed | N/A | 120 | Samsung Medical CenterOTHER | 1 | May 24, 2023 | clinicaltrials |
| NCT01488045 | Compare Propofol to Fentanyl and Midazolam for Colonoscopy | completed | N/A | 289 | Trinity Health MichiganOTHER | 1 | May 23, 2023 | clinicaltrials |
| NCT02849717 | Pre-Habilitation Exercise Intervention | completed | N/A | 82 | University of RochesterOTHER | 1 | May 16, 2023 | clinicaltrials |
| NCT03028831 | Fiber to Reduce Colon Cancer in Alaska Native People | completed | N/A | 48 | University of PittsburghOTHER | 1 | May 16, 2023 | clinicaltrials |
| NCT01420874 | Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer) | completed | Phase 1 | 15 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT05553080 | Significance of Immunohistochemical Expression of Fascin-1 in Colorectal Carcinoma | completed | — | 60 | Sohag UniversityOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT04067778 | IBD Neoplasia Surveillance Pilot RCT(IBDDysplasia) | completed | N/A | 600 | Ottawa Hospital Research InstituteOTHER | 1 | Mar 31, 2023 | clinicaltrials |
| NCT04080414 | Home-based HIIT to Improve CRC Survivorship: Feasibility and Relationship With Novel Surrogate Biomarkers of CRC Recurrence | completed | N/A | 7 | University of UtahOTHER | 1 | Mar 22, 2023 | clinicaltrials |
| NCT03801915 | Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers | completed | Phase 2 | 10 | National Cancer Institute (NCI)NIH | 1 | Mar 21, 2023 | clinicaltrials |
| NCT03723720 | Calculating of Correlations Between ADR, PDR, MAP | completed | — | 6,925 | Hospital Frydek-MistekOTHER | 1 | Mar 2, 2023 | clinicaltrials |
| NCT03750461 | Stoma Closure and Reinforcement Trial(SCAR) | completed | N/A | 20 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Feb 22, 2023 | clinicaltrials |
| NCT04548531 | Engaging Patients in Colon Cancer Screening Decisions During COVID-19 | completed | N/A | 800 | Massachusetts General HospitalOTHER | 1 | Feb 22, 2023 | clinicaltrials |
| NCT05034185 | Real-World Validation of an Artificial Intelligence Characterization Support (CADx) System | completed | — | 450 | Changi General HospitalOTHER | 1 | Feb 22, 2023 | clinicaltrials |
| NCT02890758 | Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 | completed | Phase 1 | 14 | Brenda Cooper, MDOTHER | 1 | Feb 21, 2023 | clinicaltrials |
| NCT03871959 | Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic Adenocarcinoma(CATRIPCA) | completed | Phase 1 | 54 | Centre Leon BerardOTHER | 1 | Feb 17, 2023 | clinicaltrials |
| NCT03462706 | Quad Resection (Hot Snare vs Cold Snare vs Hot EMR vs Cold EMR) | completed | N/A | 238 | Indiana UniversityOTHER | 1 | Feb 15, 2023 | clinicaltrials |
| NCT03871790 | Peptide-based Immunization for Colon- and and Pancreas-carcinoma(PICOP-GLOBAL) | completed | — | 50 | CENTOGENE GmbH RostockINDUSTRY | 1 | Feb 10, 2023 | clinicaltrials |
| NCT05638048 | Effect of Precise Grip Strength Training on PICC Catheter-Related Thrombosis in Cancer Patients | completed | N/A | 270 | Junyan ZhaoOTHER | 1 | Feb 3, 2023 | clinicaltrials |
| NCT02728804 | S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer | completed | — | 380 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 26, 2023 | clinicaltrials |
| NCT02324374 | Endocytoscopy and Colorectal Neoplasia | completed | N/A | 50 | University of PennsylvaniaOTHER | 1 | Jan 25, 2023 | clinicaltrials |
| NCT04476082 | Nutrition in Gastrointestinal Tumors(NutriGIT) | completed | — | 66 | University Medicine GreifswaldOTHER | 1 | Jan 25, 2023 | clinicaltrials |
| NCT05675904 | Textbook Outcome in Colon Carcinoma | completed | — | 564 | Hospital General Universitario de AlicanteOTHER | 1 | Jan 9, 2023 | clinicaltrials |
| NCT03407716 | Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors | completed | Early Phase 1 | 2 | Mayo ClinicOTHER | 1 | Jan 5, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Nov 22, 2023source: clinicaltrials